Thomas E Lloyd1, Andrew L Mammen2, Anthony A Amato2, Michael D Weiss2, Merrilee Needham2, Steven A Greenberg1. 1. From the Departments of Neurology (T.E.L., A.L.M.), Neuroscience (T.E.L.), and Medicine (A.L.M.), Johns Hopkins University School of Medicine and Johns Hopkins Bayview Myositis Center, Baltimore, MD; Department of Neurology (A.A.A., S.A.G.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Neurology (M.D.W.), University of Washington, Seattle; Department of Neurology (M.N.), Australian Neuromuscular Research Institute, University of Western Australia; and Children's Hospital Informatics Program (S.A.G.), Boston Children's Hospital and Harvard-MIT Division of Health Sciences and Technology, Boston, MA. tlloyd4@jhmi.edu sagreenberg@partners.org. 2. From the Departments of Neurology (T.E.L., A.L.M.), Neuroscience (T.E.L.), and Medicine (A.L.M.), Johns Hopkins University School of Medicine and Johns Hopkins Bayview Myositis Center, Baltimore, MD; Department of Neurology (A.A.A., S.A.G.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Neurology (M.D.W.), University of Washington, Seattle; Department of Neurology (M.N.), Australian Neuromuscular Research Institute, University of Western Australia; and Children's Hospital Informatics Program (S.A.G.), Boston Children's Hospital and Harvard-MIT Division of Health Sciences and Technology, Boston, MA.
Abstract
OBJECTIVE: To use patient data to evaluate and construct diagnostic criteria for inclusion body myositis (IBM), a progressive disease of skeletal muscle. METHODS: The literature was reviewed to identify all previously proposed IBM diagnostic criteria. These criteria were applied through medical records review to 200 patients diagnosed as having IBM and 171 patients diagnosed as having a muscle disease other than IBM by neuromuscular specialists at 2 institutions, and to a validating set of 66 additional patients with IBM from 2 other institutions. Machine learning techniques were used for unbiased construction of diagnostic criteria. RESULTS: Twenty-four previously proposed IBM diagnostic categories were identified. Twelve categories all performed with high (≥97%) specificity but varied substantially in their sensitivities (11%-84%). The best performing category was European Neuromuscular Centre 2013 probable (sensitivity of 84%). Specialized pathologic features and newly introduced strength criteria (comparative knee extension/hip flexion strength) performed poorly. Unbiased data-directed analysis of 20 features in 371 patients resulted in construction of higher-performing data-derived diagnostic criteria (90% sensitivity and 96% specificity). CONCLUSIONS: Published expert consensus-derived IBM diagnostic categories have uniformly high specificity but wide-ranging sensitivities. High-performing IBM diagnostic category criteria can be developed directly from principled unbiased analysis of patient data. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that published expert consensus-derived IBM diagnostic categories accurately distinguish IBM from other muscle disease with high specificity but wide-ranging sensitivities.
OBJECTIVE: To use patient data to evaluate and construct diagnostic criteria for inclusion body myositis (IBM), a progressive disease of skeletal muscle. METHODS: The literature was reviewed to identify all previously proposed IBM diagnostic criteria. These criteria were applied through medical records review to 200 patients diagnosed as having IBM and 171 patients diagnosed as having a muscle disease other than IBM by neuromuscular specialists at 2 institutions, and to a validating set of 66 additional patients with IBM from 2 other institutions. Machine learning techniques were used for unbiased construction of diagnostic criteria. RESULTS: Twenty-four previously proposed IBM diagnostic categories were identified. Twelve categories all performed with high (≥97%) specificity but varied substantially in their sensitivities (11%-84%). The best performing category was European Neuromuscular Centre 2013 probable (sensitivity of 84%). Specialized pathologic features and newly introduced strength criteria (comparative knee extension/hip flexion strength) performed poorly. Unbiased data-directed analysis of 20 features in 371 patients resulted in construction of higher-performing data-derived diagnostic criteria (90% sensitivity and 96% specificity). CONCLUSIONS: Published expert consensus-derived IBM diagnostic categories have uniformly high specificity but wide-ranging sensitivities. High-performing IBM diagnostic category criteria can be developed directly from principled unbiased analysis of patient data. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that published expert consensus-derived IBM diagnostic categories accurately distinguish IBM from other muscle disease with high specificity but wide-ranging sensitivities.
Authors: U A Badrising; M Maat-Schieman; S G van Duinen; F Breedveld; P van Doorn; B van Engelen; F van den Hoogen; J Hoogendijk; C Höweler; A de Jager; F Jennekens; P Koehler; H van der Leeuw; M de Visser; J J Verschuuren; A R Wintzen Journal: Neurology Date: 2000-11-14 Impact factor: 9.910
Authors: M Needham; I James; A Corbett; T Day; F Christiansen; B Phillips; F L Mastaglia Journal: J Neurol Neurosurg Psychiatry Date: 2008-02-07 Impact factor: 10.154
Authors: Jason Hom; Shruti Marwaha; Anna Postolova; Jessie Kittle; Rosaline Vasquez; Jean Davidson; Jennefer Kohler; Annika Dries; Liliana Fernandez-Betancourt; Marta Majcherska; Joanna Dearlove; Shyam Raghavan; Hannes Vogel; Jonathan A Bernstein; Paul Fisher; Euan Ashley; Jacinda Sampson; Matthew Wheeler Journal: J Gen Intern Med Date: 2019-03-18 Impact factor: 5.128
Authors: Thomas E Lloyd; Lisa Christopher-Stine; Iago Pinal-Fernandez; Eleni Tiniakou; Michelle Petri; Alan Baer; Sonye K Danoff; Katherine Pak; Livia A Casciola-Rosen; Andrew L Mammen Journal: Arthritis Care Res (Hoboken) Date: 2016-01 Impact factor: 4.794
Authors: David F Fiorentino; Matthew Presby; Alan N Baer; Michelle Petri; Kerri E Rieger; Mark Soloski; Antony Rosen; Andrew L Mammen; Lisa Christopher-Stine; Livia Casciola-Rosen Journal: Ann Rheum Dis Date: 2015-08-07 Impact factor: 19.103